Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01874158 · ClinicalTrials.gov registry record
DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women
A clinical trial, sponsored by Tulane University Health Sciences Center.
- Completed
- Registry status
- 99
- Enrollment target
NCT01874158: Completed study, sponsored by Tulane University Health Sciences Center.
NCT01874158 is a clinical trial that has completed, run by Tulane University Health Sciences Center. The registered enrollment target is 99 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01874158 has completed, sponsored by Tulane University Health Sciences Center.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
The objective of this study is to screen treated Trichomonas vaginalis (TV) positive women weekly using culture and Polymerase Chain Reaction (PCR) to determine how long TV DNA is detectable post treatment and to examine potential confounders to clearance such as bacterial vaginosis.
Primary Outcome
Women are assessed for TV at each weekly visit by PCR. They are considered cleared of the remnant DNA after PCR is negative.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-04 |
What the finished NCT01874158 record still lists
NCT01874158 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01874158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01874158 about?
NCT01874158 is a clinical study titled "DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women". The objective of this study is to screen treated Trichomonas vaginalis (TV) positive women weekly using culture and Polymerase Chain Reaction (PCR) to determine how long TV DNA is detectable post treatment and to examine potential confounders to clearance such as bacterial vaginosis.
What is the current status of trial NCT01874158?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2012-11. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01874158?
This trial is sponsored by Tulane University Health Sciences Center, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia